Regulatory B cells control airway hyperreactivity and lung remodeling in a murine asthma model.

Habener, Anika; Happle, Christine; Grychtol, Ruth; Skuljec, Jelena; Busse, Mandy; Dalüge, Kathleen; Obernolte, Helena; Sewald, Katherina et al. · J Allergy Clin Immunol · 2021

basic_science · Level V

Where this comes from

Abstract

Asthma is a widespread, multifactorial chronic airway disease. The influence of regulatory B cells on airway hyperreactivity (AHR) and remodeling in asthma is poorly understood. Our aim was to analyze the role of B cells in a house dust mite (HDM)-based murine asthma model. The influence of B cells on lung function, tissue remodeling, and the immune response were analyzed by using wild-type and B-cell-deficient (μMT) mice and transfer of IL-10-proficient and IL-10-deficient B cells to μMT mice. After HDM-sensitization, both wild-type and μMT mice developed AHR, but the AHR was significantly stronger in μMT mice, as confirmed by 2 independent techniques: invasive lung function measurement in vivo and examination of precision-cut lung slices ex vivo. Moreover, airway remodeling was significantly increased in allergic μMT mice, as shown by enhanced collagen deposition in the airways, whereas the numbers of FoxP3<sup>+</sup> and FoxP3<sup>-</sup> IL-10-secreting regulatory T cells were reduced. Adoptive transfer of IL-10-proficient but not IL-10-deficient B cells into μMT mice before HDM-sensitization attenuated AHR and lung remodeling. In contrast, FoxP3<sup>+</sup> regulatory T cells were equally upregulated by transfer of IL-10-proficient and IL-10-deficient B cells. Our data in a murine asthma model illustrate a central role of regulatory B cells in the control of lung function and airway remodeling and may support future concepts for B-cell-targeted prevention and treatment strategies for allergic asthma.

Medical subject headings